Company
Headquarters: Osaka, Japan
Employees: 274
CEO: Mr. Takashi Shibata
¥22.42 Billion
JPY as of July 1, 2024
US$138.8 Million
Company | Market Cap (USD) |
---|---|
Lilly | $808.65 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $450.89 B |
Johnson & Johnson | $350.63 B |
Merck | $318.75 B |
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as LISPASS Cleverin generator, a machine which emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. In addition, the company manufactures and sells bath additives and pyroligneous acids for horticultural use. It operates in Japan, China, Hong Kong, Taiwan, Thailand, Malaysia, Vietnam, Mongolia, the United States, and Canada. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Taiko Pharmaceutical Co.,Ltd. has the following listings and related stock indices.
Stock: JPX: 4574 wb_incandescent